Αλέξανδρος Σφακιανάκης,
IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors Purpose…
IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors
Overview of attention for article published in Clinical Cancer Research, April 2018
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (73rd percentile)
-
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)
Mentioned by
- policy
- 1 policy source
- 5 X users
- googleplus
- 1 Google+ user
- f1000
- 1 research highlight platform
Readers on
- mendeley
- 84 Mendeley